MedPath

Beta-blockers in chronic obstructive pulmonary disease (COPD): Feasibility study

Active, not recruiting
Conditions
COPD
Respiratory - Chronic obstructive pulmonary disease
Registration Number
ACTRN12616000839404
Lead Sponsor
Robert Hancox
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Clinical diagnosis of COPD
FEV1/FVC ratio <70% on spirometery
History of COPD exacerbation in previous 2 years
Currently clinically stable

Exclusion Criteria

Clinical diagnosis of asthma
Contraindication to beta-blockers
Active cancer or terminal illness
Pregnant or breastfeeding
Acute coronary syndrome

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath